Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2

被引:24
作者
Helias, Catherine [1 ]
Struski, Stephanie [1 ]
Gervais, Carine [1 ]
Leymarie, Vincent [1 ]
Mauvieux, Laurent [1 ]
Herbrecht, Raoul [2 ]
Lessard, Michel [1 ]
机构
[1] Hautepierre Hosp, Hematol Lab, F-67098 Strasbourg, France
[2] Univ Hosp, Dept Onco Hematol, F-67098 Strasbourg, France
关键词
D O I
10.1016/j.cancergencyto.2007.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polycythemia vera. (PV) is a clonal stem cell disorder characterized by an excessive erythrocyte production. At diagnosis, a normal karyotype is found in <= 80% of cases, but an abnormal karyotype frequently develops with evolution. Trisomy 9 and gains on 9p are some of the most frequent cytogenetic abnormalities, together with trisomy 8 and del(20q) in both PV and idiopathic myelofibrosis. We report the case of a 54-year-old man whose disease was classified as an acute myeloid transformation of PV. Cytogenctic and multicolor fluorescence in situ hybridization (FISH) analysis detected several chromosomal abnormalities that included an amplification of 9p. Complementary FISH analysis established amplification of the 9p22 similar to p24.3 region including several known genes: MLLT3 (alias AF9), JMJD2C (alias GASC1), JAK2, and SMARCA2 (alias BRM). JAK2(V617F) mutation status was quantitatively assessed by allele-specific quantitative polymerase chain reaction. Although crossing points analysis showed JAK2(V617F) mutated alleles at 52%, it is still impossible to describe conclusively the mutational status of the amplified JAK2 gene within the sole homogeneously staining region, because total genomic DNA was extracted for the analysis and not only DNA from cells with the homogeneously staining region. Gains on 9p being among the most common anomalies in PV, amplification of a gene or genes on this region may play a crucial role in the pathogenesis or evolution of PV. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 25 条
[1]   Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study [J].
Al-Assar, O ;
Ul-Hassan, A ;
Brown, R ;
Wilson, GA ;
Hammond, DW ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) :66-71
[2]  
Andrieux Joris Loup, 2005, Curr Hematol Rep, V4, P224
[3]  
Baxter EJ, 2005, LANCET, V366, P122
[4]   CHROMOSOME-STUDIES IN 104 PATIENTS WITH POLYCYTHEMIA-VERA [J].
DIEZMARTIN, JL ;
GRAHAM, DL ;
PETITT, RM ;
DEWALD, GW .
MAYO CLINIC PROCEEDINGS, 1991, 66 (03) :287-299
[5]   DNA AMPLIFICATIONS ON CHROMOSOME-7, CHROMOSOME-9 AND CHROMOSOME-12 IN GLIOBLASTOMA DETECTED BY REVERSE CHROMOSOME PAINTING [J].
FISCHER, U ;
WULLICH, B ;
SATTLER, HP ;
GOTTERT, E ;
ZANG, KD ;
MEESE, E .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (08) :1124-1127
[6]   Characterization of double minute chromosomes' DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization [J].
Giollant, M ;
Bertrand, S ;
Verrelle, P ;
Tchirkov, A ;
duManoir, S ;
Ried, T ;
Mornex, F ;
Dore, JF ;
Cremer, T ;
Malet, P .
HUMAN GENETICS, 1996, 98 (03) :265-270
[7]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[8]  
Joos S, 2000, CANCER RES, V60, P549
[9]   Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2 [J].
Joos, S ;
Granzow, M ;
Holtgreve-Grez, H ;
Siebert, R ;
Harder, L ;
Martín-Subero, JI ;
Wolf, J ;
Adamowicz, M ;
Barth, TFE ;
Lichter, P ;
Jauch, A .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (04) :489-495
[10]   A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].
Kralovics, R ;
Passamonti, F ;
Buser, AS ;
Teo, S ;
Tiedt, R ;
Passweg, JR ;
Tichelli, A ;
Cazzola, M ;
Skoda, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790